Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 182

1.

Outbreak of CTX-M-15-producing Enterobacter cloacae associated with therapeutic beds and syphons in an intensive care unit.

Bousquet A, van der Mee-Marquet N, Dubost C, Bigaillon C, Larréché S, Bugier S, Surcouf C, Mérat S, Blanchard H, Mérens A.

Am J Infect Control. 2017 May 29. pii: S0196-6553(17)30326-7. doi: 10.1016/j.ajic.2017.04.010. [Epub ahead of print]

PMID:
28571981
2.

Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.

Polaris Observatory HCV Collaborators.

Lancet Gastroenterol Hepatol. 2017 Mar;2(3):161-176. doi: 10.1016/S2468-1253(16)30181-9. Epub 2016 Dec 16.

PMID:
28404132
3.

Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial.

Mofidi F, Poustchi H, Yari Z, Nourinayyer B, Merat S, Sharafkhah M, Malekzadeh R, Hekmatdoost A.

Br J Nutr. 2017 Mar;117(5):662-668. doi: 10.1017/S0007114517000204. Epub 2017 Mar 27.

PMID:
28345499
4.

Causes and Characteristics of Death in Intensive Care Units: A Prospective Multicenter Study.

Orban JC, Walrave Y, Mongardon N, Allaouchiche B, Argaud L, Aubrun F, Barjon G, Constantin JM, Dhonneur G, Durand-Gasselin J, Dupont H, Genestal M, Goguey C, Goutorbe P, Guidet B, Hyvernat H, Jaber S, Lefrant JY, Mallédant Y, Morel J, Ouattara A, Pichon N, Guérin Robardey AM, Sirodot M, Theissen A, Wiramus S, Zieleskiewicz L, Leone M, Ichai C; AzuRéa Network.

Anesthesiology. 2017 May;126(5):882-889. doi: 10.1097/ALN.0000000000001612.

PMID:
28296682
5.

Two Triacylglycerol Pathway Genes, CTDNEP1 and LPIN1, are Down-Regulated by hsa-miR-122-5p in Hepatocytes.

Naderi M, Pazouki A, Arefian E, Hashemi SM, Jamshidi-Adegani F, Gholamalamdari O, Soudi S, Azadmanesh K, Mirab Samiee S, Merat S, Gholami Fesharaki M, Mondanizadeh M, Vasei M, Soleimani M.

Arch Iran Med. 2017 Mar;20(3):165-171. doi: 0172003/AIM.009.

6.

Role of serum level and genetic variation of IL-28B in interferon responsiveness and advanced liver disease in chronic hepatitis C patients.

Alborzi A, Hashempour T, Moayedi J, Musavi Z, Pouladfar G, Merat S.

Med Microbiol Immunol. 2017 Apr;206(2):165-174. doi: 10.1007/s00430-017-0497-y. Epub 2017 Feb 18.

PMID:
28214926
7.

The Presence of Autoantibodies to Cytoplasmic Rod and Ring Particles in the Serum of Patients with Chronic Hepatitis C Virus Infection.

Afsharzadeh F, Bokharaei-Salim F, Esghaei M, Monavari SH, Merat S, Poustchi H, Haj-Sheykholeslami A, Keyvani H.

Hepat Mon. 2016 Dec 11;16(12):e42388. doi: 10.5812/hepatmon.42388. eCollection 2016 Dec.

8.

Hazards of cigarettes, smokeless tobacco and waterpipe in a Middle Eastern Population: a Cohort Study of 50 000 individuals from Iran.

Etemadi A, Khademi H, Kamangar F, Freedman ND, Abnet CC, Brennan P, Malekzadeh R; Golestan Cohort Study Team.

Tob Control. 2016 Nov 21. pii: tobaccocontrol-2016-053245. doi: 10.1136/tobaccocontrol-2016-053245. [Epub ahead of print]

PMID:
27872345
9.

Central Obesity and Liver Iron Content: A Noninvasive Assessment in General Population by Magnetic Resonance Imaging.

Radmard AR, Poustchi H, Hashemi Taheri AP, Gerami Seresht M, Mohammadinejad P, Yoonessi A, Dadgostar M, Rahmanian MS, Jafari E, Zeinoddini A, Malekzadeh R, Merat S.

Ann Nutr Metab. 2016;69(3-4):181-189. doi: 10.1159/000453111. Epub 2016 Nov 18.

PMID:
27855393
10.

Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline.

Alavian SM, Hajarizadeh B, Bagheri Lankarani K, Sharafi H, Ebrahimi Daryani N, Merat S, Mohraz M, Mardani M, Fattahi MR, Poustchi H, Nikbin M, Nabavi M, Adibi P, Ziaee M, Behnava B, Rezaee-Zavareh MS, Colombo M, Massoumi H, Bizri AR, Eghtesad B, Amiri M, Namvar A, Hesamizadeh K, Malekzadeh R.

Hepat Mon. 2016 Aug 13;16(8):e40959. eCollection 2016 Aug. Review.

11.

Hepatitis C virus Broadly Neutralizing Monoclonal Antibodies Isolated 25 Years after Spontaneous Clearance.

Merat SJ, Molenkamp R, Wagner K, Koekkoek SM, van de Berg D, Yasuda E, Böhne M, Claassen YB, Grady BP, Prins M, Bakker AQ, de Jong MD, Spits H, Schinkel J, Beaumont T.

PLoS One. 2016 Oct 24;11(10):e0165047. doi: 10.1371/journal.pone.0165047. eCollection 2016.

12.

Assessment of Abdominal Fat Distribution in Non-Alcoholic Fatty Liver Disease by Magnetic Resonance Imaging: a Population-based Study.

Radmard AR, Rahmanian MS, Abrishami A, Yoonessi A, Kooraki S, Dadgostar M, Hashemi Taheri AP, Gerami Seresht M, Poustchi H, Jafari E, Malekzadeh R, Merat S.

Arch Iran Med. 2016 Oct;19(10):693-699.

13.

Liver Disease Burden of Hepatitis C Virus Infection in Iran and the Potential Impact of Various Treatment Strategies on the Disease Burden.

Hajarizadeh B, Razavi-Shearer D, Merat S, Alavian SM, Malekzadeh R, Razavi H.

Hepat Mon. 2016 Jun 14;16(7):e37234. doi: 10.5812/hepatmon.37234. eCollection 2016 Jul.

14.

Reliability Analysis of a Newly Developed Questionnaire for Quality Control of Follow-up Visits in PolyIran Study.

Roshandel G, Ostovaneh MR, Poustchi H, Malekzadeh F, Sepanlou SG, Honarvar MR, Semnani S, Merat S, Malekzadeh R.

Arch Iran Med. 2016 Aug;19(8):551-5. doi: 0161908/AIM.006.

15.

Triage in military settings.

Falzone E, Pasquier P, Hoffmann C, Barbier O, Boutonnet M, Salvadori A, Jarrassier A, Renner J, Malgras B, Mérat S.

Anaesth Crit Care Pain Med. 2017 Feb;36(1):43-51. doi: 10.1016/j.accpm.2016.05.004. Epub 2016 Jul 30. Review.

PMID:
27481690
16.

Effects of Pomegranate and Orange Juice on Antioxidant Status in Non-Alcoholic Fatty Liver Disease Patients: A Randomized Clinical Trial.

Ekhlasi G, Shidfar F, Agah S, Merat S, Hosseini AF.

Int J Vitam Nutr Res. 2016 Jul 14:1-7. [Epub ahead of print]

PMID:
27414418
17.

A Serious Game for Massive Training and Assessment of French Soldiers Involved in Forward Combat Casualty Care (3D-SC1): Development and Deployment.

Pasquier P, Mérat S, Malgras B, Petit L, Queran X, Bay C, Boutonnet M, Jault P, Ausset S, Auroy Y, Perez JP, Tesnière A, Pons F, Mignon A.

JMIR Serious Games. 2016 May 18;4(1):e5. doi: 10.2196/games.5340.

18.

Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants.

NCD Risk Factor Collaboration (NCD-RisC).

Lancet. 2016 Apr 9;387(10027):1513-30. doi: 10.1016/S0140-6736(16)00618-8. Epub 2016 Apr 6.

19.

Effects of Synbiotics Supplementation in Lean Patients with Nonalcoholic Fatty Liver Disease: Study Protocol of a Pilot Randomized Double-blind Clinical Trial.

Mofidi F, Yari Z, Poustchi H, Merat S, Nourinayyer B, Malekzadeh R, Hekmatdoost A.

Arch Iran Med. 2016 Apr;19(4):282-4. doi: 0161904/AIM.000010.

20.

Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort.

Foster GR, Coppola C, Derbala M, Ferenci P, Orlandini A, Reddy KR, Tallarico L, Shiffman ML, Ahlers S, Bakalos G, Hassanein T; GUARD-C Study Group.

PLoS One. 2016 Mar 28;11(3):e0151703. doi: 10.1371/journal.pone.0151703. eCollection 2016.

Supplemental Content

Loading ...
Support Center